Doctolib, @Hôtel-Dieu (AP-HP) and Roche are launching Care Forward, a support program for European health startups at STATION F.
Designed to help young companies develop, test and deploy their solutions as close as possible to care delivery needs, it brings together technological expertise, access to clinical environments, and medical and regulatory support.
Based in the heart of STATION F, this program targets European startups that can demonstrate a rapid, measurable impact on the healthcare system, regardless of their maturity stage. It aims to accelerate the rollout of practical solutions, ready to be proven in real-world settings and to meet the daily requirements of healthcare professionals and patients’ needs.
The program is open to both early- and late-stage, developing technologies dedicated to the healthcare sector, whether digital solutions, AI, connected devices, or services.
Projects may focus on a specific step of the care pathway — identification, diagnosis, treatment or follow-up — as well as innovations that improve the overall efficiency of the healthcare system.
Any technological contribution demonstrating a concrete impact on the healthcare system is welcome to join this new initiative.
- Doctolib will support program participants with technology integration, the use of AI in healthcare, an in-depth understanding of practitioners’ expectations, and deployment strategies at the European scale.
- @Hôtel-Dieu (AP-HP) will provide privileged access to AP-HP innovation platforms designed to support the emergence of innovation in the service of healthcare, and through them, to hospital environments. Startups will be able to engage directly with clinical realities, align their solutions with real-world needs, and leverage the expertise of professionals across the 38 hospitals of Europe’s largest university hospital system.
- Roche will provide essential strategic support to navigate the sector’s complexity. Its teams will help entrepreneurs master regulatory constraints, demonstrate the health economic value of their projects, and gain access to a global network of scientific experts.
In addition to this hands-on support, the program includes regular meetings with specialised investors and key industry stakeholders, as well as exclusive invitations to events across Europe’s health ecosystem.
According to Jean-Urbain Hubau, Managing Director, France, Doctolib:
“Our healthtech ecosystem is full of talent, but the real challenge remains scaling and adoption by healthcare professionals. With this program, we want to give startups the codes and tools so their innovations truly—and quickly—make it into the daily lives of care teams and patients.”
According to Nicolas Castoldi, Deputy Director to the CEO of AP-HP and Executive Director of the @Hôtel-Dieu:
“This program is a further demonstration of our commitment to accelerating the emergence of innovation as close as possible to care delivery, in order to better meet the needs of healthcare professionals and patients.
It builds on our innovation platforms and supports the development of the new Hôtel-Dieu, a major innovation hub at the heart of a hospital with 14 centuries of history.”
According to Jean-François Brochard, President, Roche Pharma France:
“This program will combine our longstanding expertise with the innovation capacity of healthtech startups.
Our shared ambition is to optimise care pathways to ensure lasting benefits for patients, simplify the daily work of care teams, and strengthen the efficiency of our healthcare system.”
Applications for the program are open until May 15th.
